SOLIGENIX, INC. Earnings Per Share, Basic and Diluted
SOLIGENIX, INC. (SNGX) reported Earnings Per Share, Basic and Diluted of -$0.09 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-12
- SOLIGENIX, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.09.
- SOLIGENIX, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.05.
- SOLIGENIX, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.06.
- SOLIGENIX, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.18.
- SOLIGENIX, INC. earnings per share, basic and diluted for fiscal 2020 was -$0.64.
- SOLIGENIX, INC. earnings per share, basic and diluted for fiscal 2019 was -$0.48.
- SOLIGENIX, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.68.
- SOLIGENIX, INC. earnings per share, basic and diluted for fiscal 2017 was -$1.16.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2021-09-30 | -$0.09 10-Q · filed 2021-11-12 | -$0.14 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.20 10-Q · filed 2021-11-12 | -$0.36 derived: net income ÷ weighted average shares · filed 2022-11-10 | |||
| 2021-06-30 | -$0.05 10-Q · filed 2021-08-13 | -$0.11 10-Q · filed 2021-08-13 | -$0.27 derived: net income ÷ weighted average shares · filed 2022-08-12 | -$0.34 derived: net income ÷ weighted average shares · filed 2022-08-12 | |||
| 2021-03-31 | -$0.06 10-Q · filed 2021-05-18 | -$0.24 derived: net income ÷ weighted average shares · filed 2022-05-13 | -$0.30 derived: net income ÷ weighted average shares · filed 2022-05-13 | -$0.40 derived: net income ÷ weighted average shares · filed 2022-05-13 | |||
| 2020-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2022-03-29 | -$0.25 derived: net income ÷ weighted average shares · filed 2022-03-29 | -$0.35 derived: net income ÷ weighted average shares · filed 2022-03-29 | -$0.64 10-K · filed 2021-03-30 | |||
| 2020-09-30 | -$0.06 10-Q · filed 2021-11-12 | -$0.16 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.45 10-Q · filed 2021-11-12 | ||||
| 2020-06-30 | -$0.10 10-Q · filed 2021-08-13 | -$0.41 10-Q · filed 2021-08-13 | |||||
| 2020-03-31 | -$0.32 10-Q · filed 2021-05-18 | ||||||
| 2019-12-31 | -$0.48 10-K · filed 2021-03-30 | ||||||
| 2019-09-30 | -$0.14 10-Q · filed 2020-11-12 | -$0.34 10-Q · filed 2020-11-12 | |||||
| 2019-06-30 | -$0.12 10-Q · filed 2020-08-14 | -$0.21 10-Q · filed 2020-08-14 | |||||
| 2019-03-31 | -$0.09 10-Q · filed 2020-05-15 | ||||||
| 2018-12-31 | -$0.68 10-K · filed 2020-03-30 | ||||||
| 2018-09-30 | -$0.11 10-Q · filed 2019-11-12 | -$0.50 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | -$0.18 10-Q · filed 2019-08-13 | -$0.45 10-Q · filed 2019-08-13 | |||||
| 2018-03-31 | -$0.27 10-Q · filed 2019-05-14 | ||||||
| 2017-12-31 | -$1.16 10-K · filed 2019-03-26 | ||||||
| 2015-06-30 | -$0.15 10-Q · filed 2015-08-12 | -$0.34 10-Q · filed 2015-08-12 | |||||
| 2015-03-31 | -$0.19 10-Q · filed 2015-05-14 | ||||||
| 2014-06-30 | -$0.05 10-Q · filed 2015-08-12 | -$0.22 10-Q · filed 2015-08-12 | |||||
| 2014-03-31 | -$0.17 10-Q · filed 2015-05-14 | ||||||
| 2013-12-31 | -$0.65 10-K · filed 2014-03-26 | ||||||
| 2013-09-30 | -$0.34 10-Q · filed 2013-11-12 | -$0.78 10-Q · filed 2013-11-12 | |||||
| 2013-06-30 | -$0.28 10-Q · filed 2014-08-11 | -$0.38 10-Q · filed 2014-08-11 | |||||
| 2013-03-31 | -$0.10 10-Q · filed 2014-05-12 | ||||||
| 2012-12-31 | -$0.37 10-K · filed 2014-03-26 | ||||||
| 2012-09-30 | -$0.07 10-Q · filed 2013-11-12 | -$0.29 10-Q · filed 2013-11-12 | |||||
| 2012-06-30 | -$0.09 10-Q · filed 2013-08-12 | -$0.22 10-Q · filed 2013-08-12 | |||||
| 2012-03-31 | -$0.13 10-Q · filed 2013-05-03 | ||||||
| 2011-12-31 | -$0.22 10-K · filed 2013-02-26 | ||||||
| 2011-09-30 | $0.20 10-Q · filed 2012-11-14 | $0.01 10-Q · filed 2011-11-14 | -$0.13 10-Q · filed 2012-11-14 | -$0.01 10-Q · filed 2011-11-14 | |||
| 2011-06-30 | -$0.18 10-Q · filed 2012-08-10 | -$0.01 10-Q · filed 2011-08-12 | -$0.34 10-Q · filed 2012-08-10 | -$0.02 10-Q · filed 2011-08-12 | |||
| 2011-03-31 | -$0.16 10-Q · filed 2012-05-14 | ||||||
| 2010-12-31 | -$0.73 10-K · filed 2012-03-27 | ||||||
| 2010-09-30 | -$0.01 10-Q · filed 2011-11-14 | -$0.03 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | -$0.01 10-Q · filed 2011-08-12 | -$0.02 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |